logo
Sign in

ENCODIA INC

Rockville, MD · Biotech · Defunct

Single-molecule digital peptide sequencing platform using parallelized Edman degradation and DNA encoding for proteome analysis

Claim this profile

Follows are private to you and power your alerts

Updated · encodia.com

Sector
Biotech
Headquarters
Rockville, MD
Total capital
$9.1M
Federal grants
$9.1M
16 awards · 2016–2021
Rank in peer group#24 of 36
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
21
19 pending · first 2023
Rank in peer group#2 of 36

Capital timeline

201620172018201920202021FEDERAL ↑EQUITY ↓Cumulative $9.1M$2.2M$732K$737K$729K$750K$737K
201620172018201920202021FEDERAL ↑EQUITY ↓Cumulative $9.1M$2.2M$737K$750K$737K

Latest events

  • Federal grantHealth and Human S · Phase II · Design and directed evolution of an 'Edmanase' enzyme for high-throughput peptide sequencing.$715K
  • Federal grantHealth and Human S · Phase I · HT protein profiling with a Next-Gen Protein Assay (NGPA)$256K
  • Federal grantHealth and Human S · Phase II · Directed evolution of N-terminal amino acid binding proteins for application to protein sequencing$737K
  • Federal grantHealth and Human S · Phase II · Design and directed evolution of an 'Edmanase' enzyme for high-throughput peptide sequencing.$750K
  • Federal grantHealth and Human S · Phase II · Development of Population Level Serotyping Technology and Antibody Profiling for Infectious Pathogens with focus on Influenza and SARS-CoV-2$729K
  • Federal grantHealth and Human S · Phase II · Directed evolution of N-terminal amino acid binding proteins for application to protein sequencing$737K
  • Federal grantHealth and Human S · Phase I · Development of Engineered Trypsin for Proteomics Sample Prep.$225K
Show 9 earlier federal awards
  • Federal grantHealth and Human S · Phase II · Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer$732K
  • Federal grantHealth and Human S · Phase I · Development of Engineered Trypsin for Proteomics Sample Prep.$225K
  • Federal grantHealth and Human S · Phase II · Development of Population Level Serotyping Technology and Antibody Profiling for Infectious Pathogens with focus on Influenza and SARS-CoV-2$2.2M
  • Federal grantHealth and Human S · Phase II · Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer$718K
  • Federal grantHealth and Human S · Phase I · Design and directed evolution of an 'Edmanase' enzyme for high-throughput peptide sequencing$223K
  • Federal grantHealth and Human S · Phase I · Design and directed evolution of an 'Edmanase' enzyme for high-throughput peptide sequencing$223K
  • Federal grantHealth and Human S · Phase I · Directed evolution of N-terminal amino acid binding proteins for application to protein sequencing$224K
  • Federal grantHealth and Human S · Phase I · Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer$211K
  • Federal grantHealth and Human S · Phase I · Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer$211K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 36 peers

Line = median

Biotech · Platform

  • Federal grantsBelow median
  • Granted patents#2 · top 6%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 21 granted of 40
Show all 40 patent records

Related companies, and why

  • Pinnacle MedicinesSimilar federal contract value in Biotech · null in contracts
  • THERATARGET, INC.Similar federal contract value in Biotech · null in contracts
  • Prolifagen, LLCSimilar federal contract value in Biotech · null in contracts
  • Morphic TherapeuticSimilar federal contract value in Biotech · null in contracts
  • SIEYAX, INCSimilar federal contract value in Biotech · null in contracts
  • NRG TherapeuticsSimilar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .